5-trifluoromethyl-2-azidopyridine | 118078-64-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 5-trifluoromethyl-2-azidopyridine
• 英文别名: 2-azido-5-(trifluoromethyl)pyridine
• CAS: 118078-64-1
• 化学式: C₆H₃F₃N₄
• 分子量: 188.112
• InChiKey: COAYXTOBBPXZMH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  27.2
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  乙酸乙烯酯 、 5-trifluoromethyl-2-azidopyridine 在 碳酸氢钠 作用下， 生成 5-(trifluoromethyl)-2-(1H-1,2,3-triazol-1-yl)pyridine
  参考文献：
  名称：

  Novel (1H-1,2,3-triazol-1-yl)pyridines

  摘要：

  取代了吡啶环的（1H-1,2,3-三唑-1-基）吡啶类化合物已经合成，并发现具有杀虫作用。例如，2-氯-6-(1H-1,2,3-三唑-1-基)吡啶是通过顺序缩合、水解和脱羧从2-氮杂-6-氯吡啶和丙炔酸甲酯制备而成，并发现对马齿苋叶蝉有控制作用。

  公开号：

  US04775762A1
• 作为产物：
  描述：

  2-溴-5-(三氟甲基)吡啶 在 sodium azide 作用下， 以 二甲基亚砜 为溶剂， 生成 5-trifluoromethyl-2-azidopyridine
  参考文献：
  名称：

  WO2021012018A5

  摘要：

  公开号：

  WO2021012018A5

文献信息

• 롤 화장지 인출장치
  申请人：HAN MOON KYO 한문교(419980413753)

  公开号：KR20150002661U

  公开（公告）日：2015-07-08

  본 고안은 롤 화장지 걸이대에 간편하게 장비되어 롤 화장지를 사용자가 필요한 길이로 감아 절취한 상태에서 측면 이탈 시에 구김이나 찢김 없이 용이한 인출이 제공되어 편리성이 보장되는 롤 화장지 인출장치를 제공하는 것을 목적으로 하고 있다. 본 고안의 상기 목적은 벽체에 설치되는 케이스의 내부 상측에 구비된 롤축에 중심지관으로 끼움 된 롤 화장지를 케이스의 하부로 인출하여 ‘ㄷ’자형 회전날개에 의해 소정 길이로 감고, 상기 회전날개에 감겨진 화장지를 측면으로 빼내 사용하도록 롤 화장지의 인출장치에 있어서, 상기 ‘ㄷ’자형 회전날개의 내측에 다른 ‘ㄷ’자형의 지지날개를 구비하여 상호 간이 교차 상태로 하여 각각의 회전날개와 지지날개의 외주에 롤 화장지를 소정 길이로 권취한 후 절취하고, 상기 지지날개의 역 회전에 의해 롤 화장지의 감김상태를 느슨하게 한 상태에서 측면으로 빼어 사용할 수 있도록 구성한 것을 특징으로 하는 롤 화장지 인출장치에 의해 달성된다..

  该设想旨在提供一种方便使用者将卷纸卫生纸卷取到所需长度并剪断后，当侧面脱落时能够轻松取出而无褶皱或撕裂的卷纸卫生纸取出装置，以确保便利性。该设想的上述目的通过提供一种卷纸卫生纸取出装置实现，该装置包括在安装在墙体上的盒体内部上侧配备的卷芯，通过将装有卷纸卫生纸的卷芯插入盒体底部以提取，并通过“ㄷ”字形旋转翼片将其卷成适当长度，然后从侧面取出使用的卷纸卫生纸取出装置，其中，在卷纸卫生纸取出装置中，通过在“ㄷ”字形旋转翼片的内侧配备另一个“ㄷ”字形支撑翼片，使其相互交叉状态，然后在每个旋转翼片和支撑翼片的外周上将卷纸卫生纸卷取到适当长度后剪断，并通过支撑翼片的反向旋转使卷纸卫生纸的卷曲状态变松，从而使其能够从侧面取出并使用。
• AMIDE DERIVATIVE AND USE THEREOF
  申请人：Ushio Hiroyuki

  公开号：US20130211075A1

  公开（公告）日：2013-08-15

  The present invention relates to a novel amide derivative. More specifically, the present invention provides a medicinal agent useful as a prophylactic or therapeutic agent for diseases, which relies on the production of cytokines from T cells, and which comprises an amide derivative or a pharmacologically acceptable salt thereof or a solvate of the derivative or the pharmacologically acceptable salt as an active ingredient. Provided is an amide derivative represented by general formula (I) [wherein each symbol is as defined in the description] or a pharmacologically acceptable salt thereof, or a solvate of the derivative or the pharmacologically acceptable salt.

  本发明涉及一种新型酰胺衍生物。更具体地说，本发明提供了一种药用剂，可用作依赖于T细胞产生细胞因子的疾病的预防或治疗剂，该药用剂包括酰胺衍生物或其药理学上可接受的盐或该衍生物或药理学上可接受的盐的溶剂的溶剂作为活性成分。提供的是由通式(I)所表示的酰胺衍生物[其中每个符号如描述中所定义]或其药理学上可接受的盐，或该衍生物或药理学上可接受的盐的溶剂。
• 1H,13C and15N NMR and IR studies of halogen-substituted tetrazolo[1,5-a]pyridines
  作者：P. Cmoch、H. Korczak、L. Stefaniak、G. A. Webb

  DOI：10.1002/(sici)1099-1395(199906)12:6<470::aid-poc151>3.0.co;2-u

  日期：1999.6

  The tetrazole-azide tautomerization of some halogen-substituted tetrazolo[1,5-a]pyridines was examined by IR spectroscopy at ambient temperature and by H-1,C-13 and N-15 NMR spectroscopy at various temperatures. The tetrazolopyridines can exhibit equilibrium between the azide and the tetrazole forms. For some of them slow exchange occurs on the NMR time-scale, such that it is possible to estimate equilibrium constants. The position and nature of the substituent in the pyridine ring result in stabilization or destabilization of the tetrazole form and exert a strong influence on the values found for the equilibrium constants. A saturation transfer experiment was carried out for 5-bromotetrazolo[1,5-a]pyridine and the rate constants were estimated. Moreover, based on the van't Hoff equation, the enthalpy Delta H degrees and entropy Delta S degrees for the tautomerization were calculated. Ab initio calculated energies and charge distribution are in good agreement with differences observed in the tetrazole-azide equilibrium constants. Copyright (C) 1999 John Wiley & Sons, Ltd.
• 2-Pyridylnitrene−1,3-Diazacyclohepta-1,2,4,6-tetraene Rearrangements in the Trifluoromethyl-2-pyridyl Azide Series¹^a
  作者：Richard A. Evans、Ming Wah Wong、Curt Wentrup

  DOI：10.1021/ja9541645

  日期：1996.1.1

  Photolysis of Ar matrix isolated trifluoromethyl-substituted 2-pyridyl azides/tetrazolo[1,5-a]pyridines at 12-18 K causes rapid and mostly clean conversion to the corresponding 1,3-diazacyclohepta-1,2,4,6-tetraenes (4D, 5D, 5,6D, and 4,6D) absorbing near 2000 cm(-1) in the IR. In the latter case, the intermediate 3,5-bis(trifluoromethyl)-2-pyridylnitrene (4,6N) was observed by both ESR and IR spectroscopy and converted to the diazacycloheptatetraene 4,6D in the course of 90 min of UV irradiation. The 2-pyridylnitrenes were generally observable by ESR spectroscopy (\D/hc\similar to 1.05-1.10; \E/hc\similar to 0.0 cm(-1)) following both photochemical and thermal (FVP) generation from the 2-azidopyridines. Irradiation of the Ar matrix isolated mixtures of nitrenes and diazacycloheptatetraenes also caused development of weak carbene transitions (\D/hc\similar to 0.40-0.45;\E/hc\similar to 0.006 cm(-1)) in the ESR spectra.
• INHIBITOR COMPOUNDS
  申请人：Cincera Therapeutics Pty Ltd

  公开号：EP4003986A1

  公开（公告）日：2022-06-01